Document is current
Any future updates will be listed below
-
Authors
Tanguay, Adam P.
Menon, Nikhil G.
Slavin, Emma
Moody, Mikayla
McEwen, Erin
Jay, Gregory D.
Lorenzo, Joseph
Bartley, Jenna M.
Scanlon, Vanessa M.
Deymier, Alix C.
Schmidt, Tannin A. https://orcid.org/0000-0001-7140-254X
-
Funding
Funding for this research was provided by:
UConn Health, Biomedical Engineering Department Startup Funds
UConn Health, Research Excellence Program Convergence Grant
National Institute of Allergy and Infectious Diseases (NIH/NIAID R01AI173305)
UConn Claude D. Pepper Older Americans Independence Center (NIH/NIA P30AG067988)
National Institute of Diabetes and Digestive and Kidney Diseases (5K01DK120798-05)
- License Information
-
More Information
Article History
Received: 28 March 2025
Accepted: 9 June 2025
First Online: 19 June 2025
Declarations
:
: TAS and GDJ have authored patents on rhPRG4 and hold equity in Lubris BioPharma LLC, USA. TAS is also a paid consultant for Lubris BioPharma LLC, FL. APT and JL have also authored patents on rhPRG4. All other authors have nothing to disclose.
